Ritu Shah
Chief Executive Officer bij ClostraBio, Inc.
Profiel
Ritu Shah is currently the Chief Executive Officer at ClostraBio, Inc. and the Managing Director at Portal Innovations LLC.
Previously, she held the position of Vice President-Program Management at Novartis Gene Therapies, Inc. from 2017 to 2018 and VP-Business Operations & Program Management at Levo Therapeutics, Inc. from 2018 to 2021.
She also served as the Chief Operating Officer at Pyxis Oncology, Inc. Ms. Shah completed her undergraduate degree at the University of Notre Dame.
Actieve functies van Ritu Shah
| Bedrijven | Functie | Begin |
|---|---|---|
ClostraBio, Inc.
 ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Chief Executive Officer | 24-01-2023 |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01-12-2022 |
Eerdere bekende functies van Ritu Shah
| Bedrijven | Functie | Einde |
|---|---|---|
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Corporate Officer/Principal | 01-03-2021 |
| AVEXIS INC | Corporate Officer/Principal | 01-07-2018 |
| PYXIS ONCOLOGY, INC. | Chief Operating Officer | - |
Opleiding van Ritu Shah
| University of Notre Dame | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
